0
edits
Changes
no edit summary
<tr>
<td bgcolor="#cccccc"><strong> CD144</strong></td>
<td bgcolor="#cccccc"> 135 </td> <td bgcolor="#cccccc"> Cadherin-5 VE-cadherin </td> <td bgcolor="#cccccc"> Endothelium </td> <td bgcolor="#cccccc"> Control of endothelial cell-cell adhesion, permeability, and migration </td>
</tr>
<tr>
<td><strong> CDw145</strong></td>
<td> MW not known</td>
<td> </td>
<td> Not known </td> <td> </td> <td>Not known </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD146</strong></td>
<td bgcolor="#cccccc"> 118</td> <td bgcolor="#cccccc"> A32, MCAM, MUC18, mel-CAM, S-endo </td> <td bgcolor="#cccccc"> Endothelium, a subpopulation of activated T cells </td> <td bgcolor="#cccccc"> Potential adhesion molecule</td>
</tr>
<tr>
<td><strong> CD147</strong></td>
<td> 50-60</td> <td> 5A11, basigin, CE9, HT7, M6, neurothelin, OX-47, extracellular-matrix metalloproteinase inducer (EMMPRIN), gp42 in mouse </td> <td> All leukocytes, red blood cells, platelets, and endothelial cells</td> <td> Adhesion molecule </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD148</strong></td>
<td bgcolor="#cccccc"> 240-260, 200-250</td> <td bgcolor="#cccccc"> HPTP-eta, high-cell density-enhanced PTP1 (DEP-1), p260 </td> <td bgcolor="#cccccc"> Granulocytes, monocytes, T cells, dendritic cells, platelets </td> <td bgcolor="#cccccc"> Contact inhibition of cell growth </td>
</tr>
<tr>
<td><strong> CDw149</strong></td>
<td> 120</td> <td> MEM-133 </td> <td> Peripheral-blood lymphocytes, monocytes, neutrophils, eosinophils, platelets </td> <td> Not known </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CDw150</strong></td>
<td bgcolor="#cccccc"> 75-95, 70</td> <td bgcolor="#cccccc"> IPO-3, signaling lynphocyte activation molecule (SLAM) </td> <td bgcolor="#cccccc"> Thymocytes, subpopulation of T cells, B cells, dendritic cells, endothelial cells </td> <td bgcolor="#cccccc"> B-cell co-stimulation </td>
</tr>
</tbody>
</table>